About Sparta Pharmaceuticals
Early stage pharmaceutical company engaged in commercializing technologies and drugs for treating cancer. The company focuses on acquiring compounds that have been previously tested in humans or animals and technologies that may improve the delivery or targeting of perviously tested, and in some cases marketed, anticancer agents. In addition, to lower its fixed costs of operation, the company has retained a contract drug development organization that is experienced in all phases of preclinical and clinical drug development.
Missing: Sparta Pharmaceuticals's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Sparta Pharmaceuticals's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Sparta Pharmaceuticals Frequently Asked Questions (FAQ)
When was Sparta Pharmaceuticals founded?
Sparta Pharmaceuticals was founded in 1990.
Where is Sparta Pharmaceuticals's headquarters?
Sparta Pharmaceuticals's headquarters is located at P O Box 13288, Durham.
What is Sparta Pharmaceuticals's latest funding round?
Sparta Pharmaceuticals's latest funding round is IPO.
How much did Sparta Pharmaceuticals raise?
Sparta Pharmaceuticals raised a total of $1.5M.
Who are the investors of Sparta Pharmaceuticals?
Investors of Sparta Pharmaceuticals include Edgewater Funds and Invesco.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.